DT Boumpas

2.6k citations

25 papers · 1.1k indexed · h-index 14

Co-authors: George Βertsias H Kritikos Μαγδαληνή Νάκου Dimitrios Iliopoulos Maria Hatziapostolou Prodromos Sidiropoulos René Westhovens Greet Esselens
Topics: Systemic Lupus Erythematosus Research (11 papers)Rheumatoid Arthritis Research and Therapies (8 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
Cited by: Rheumatology Immunology Nephrology
Journals: Annals of Internal Medicine Biochemical and Biophysical Research Communications Annals of the Rheumatic Diseases
Partner nations: Greece United States Belgium

In The Last Decade

DT Boumpas

25 papers receiving 1.0k citations

Peers

Countries citing papers authored by DT Boumpas

Since Specialization

Citations

This map shows the geographic impact of DT Boumpas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DT Boumpas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DT Boumpas more than expected).

Fields of papers citing papers by DT Boumpas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DT Boumpas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DT Boumpas. The network helps show where DT Boumpas may publish in the future.

Co-authorship network of co-authors of DT Boumpas

This figure shows the co-authorship network connecting the top 25 collaborators of DT Boumpas. A scholar is included among the top collaborators of DT Boumpas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DT Boumpas. DT Boumpas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	POS0421 COMBINED ANALYSIS OF METABOLIC AND TRANSCRIPTOMIC KIDNEY PROFILES OF NZW/B-F1 MURINE LUPUS UNCOVERS BIOLOGICAL MECHANISMS PRECEDING THE ONSET OF NEPHRITIS 2021 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),Dionysis Nikolopoulos,Panagiotis Garantziotis,Dimitra Benaki,Evagelos Gikas,Eleni Frangou,(unknown),DT Boumpas	2
2	FRI0236 After discontinuation of the 1st tumor necrosis factor inhibitor (TNFI), non-tnfi biologic agents have similar responses but higher survival compared to a 2nd course of a different tnfi: long-term prospective observational study of patients with rheumatoid arthritis in a tertiary hospital of greece 2017 ·Annals of the Rheumatic Diseases ·(unknown),Argyro Repa,(unknown),(unknown),Antonis Fanouriakis,(unknown),Christina Adamichou,(unknown),(unknown),(unknown),DT Boumpas,George Βertsias,Prodromos Sidiropoulos	1
3	THU0367 Familial Mediterranean Fever (FMF): A Single Center Clinical-Genetic Study 2014 ·Annals of the Rheumatic Diseases ·Argyro Repa,(unknown),(unknown),Antonis Fanouriakis,(unknown),George N. Goulielmos,DT Boumpas,Prodromos Sidiropoulos	2
4	The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study. 2014 ·PubMed ·René Westhovens,Ronald van Vollenhoven,DT Boumpas,Marek Brzosko,Katherine Svensson,Olav Bjørneboe,(unknown),Shankar Srinivasan,Philippe Gaudin,Josef S Smolen,(unknown),Rob Nelissen,Nathan Vastesaeger	10
5	SAT0006 Microrna analysis of human lupus nephritis: Evidence for modulation of kallikrein 4 by MIR-422A 2012 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),(unknown),Αikaterini Papagianni,(unknown),George Βertsias,Dimitrios Iliopoulos,DT Boumpas	2
6	Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins nephrin and podocin in experimental lupus nephritis 2012 ·Lupus ·(unknown),(unknown),George Βertsias,(unknown),Kyriacos Kyriacou,L. Nakopoulou,DT Boumpas,(unknown)	14
7	Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression 2011 ·Annals of the Rheumatic Diseases ·(unknown),George Βertsias,(unknown),Μαγδαληνή Νάκου,Maria Hatziapostolou,H Kritikos,Dimitrios Iliopoulos,DT Boumpas	244
8	PMS45 Cost-Utility and Budget Impact Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-to-Severe Active Rheumatoid Arthritis in Greece 2011 ·Value in Health ·N Maniadakis,DT Boumpas,Georgia Kourlaba,(unknown),(unknown),(unknown),O. Purcaru	2
9	Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology 2011 ·Lupus ·(unknown),(unknown),(unknown),Ioanna Giannopoulou,Kyriacos Kyriacou,L. Nakopoulou,DT Boumpas,(unknown)	52
10	Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete 2011 ·Lupus ·Elias Eliopoulos,Maria I. Zervou,(unknown),(unknown),(unknown),Georgios Voloudakis,(unknown),Vasileios Vazgiourakis,Prodromos Sidiropoulos,Timothy B. Niewold,DT Boumpas,(unknown)	42
11	High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity. 2009 ·PubMed ·John A. Papadakis,Prodromos Sidiropoulos,Stylianos Karvounaris,G. Vrentzos,Elias K. Spanakis,Emmanuel S. Ganotakis,H Kritikos,D.P. Mikhailidis,DT Boumpas	59
12	Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology. 2009 ·PubMed ·Amalia Raptopoulou,Prodromos Sidiropoulos,(unknown),Kyriaki Boki,Alexandros A. Drosos,(unknown),D. Karras,Dimitrios Pikazis,Dimitrios Vassilopoulos,Fotini B. Karassa,DT Boumpas	8
13	Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response 2009 ·Lupus ·(unknown),Maria Tzardi,George Βertsias,(unknown),DT Boumpas	55
14	Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists 2008 ·Lara D. Veeken ·Prodromos Sidiropoulos,Gülen Hatemi,In‐Ho Song,Jérôme Avouac,Eduardo Collantes‐Estévez,Vedat Hamuryudan,(unknown),Tore K Kvien,Herman Mielants,J. Mulero Mendoza,Ignazio Olivieri,Mikkel Østergaard,Lionel Schachna,Joachim Sieper,DT Boumpas,Maxime Dougados	72
15	Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future – the EULAR recommendations for the management of SLE and the use of end-points in clinical trials 2008 ·Lupus ·George Βertsias,Caroline Gordon,DT Boumpas	40
16	EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases 2007 ·Annals of the Rheumatic Diseases ·Jos N. Hoes,Johannes W. G. Jacobs,Maarten Boers,DT Boumpas,Frank Buttgereit,N. Caeyers,Ernest Choy,Maurizio Cutolo,José António Pereira da Silva,Greet Esselens,Loı̈c Guillevin,Ingiäld Hafström,John Kirwan,J Rovenský,Anthony S. Russell,Kenneth G. Saag,Björn Svensson,René Westhovens,H. Zeidler,J. W. J. Bijlsma	281
17	Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of ‘intermediate risk’ 2007 ·Clinical Genetics ·(unknown),Elias Eliopoulos,Eleni Petraki,Prodromos Sidiropoulos,Ivona Aksentijevich,E. Galanakis,H Kritikos,Argyro Repa,(unknown),DT Boumpas,(unknown)	23
18	Chronic alcohol consumption as a predisposing factor for multiple tendon ruptures in unusual sites in a patient with rheumatoid arthritis. 2007 ·PubMed ·Leonidas A. Bourikas,(unknown),(unknown),(unknown),DT Boumpas,Prodromos Sidiropoulos	6
19	Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease. 2007 ·PubMed ·Κατερίνα Αντωνίου,(unknown),Katerina Malagari,(unknown),Demosthenes Bouros,Nikolaos M. Siafakas,DT Boumpas	66
20	Membranous Nephropathy 1992 ·Annals of Internal Medicine ·H A Austin,Tatiana T. Antonovych,Karen Mackay,DT Boumpas,James E. Balow	31

About DT Boumpas

DT Boumpas is a scholar working on Rheumatology, Immunology and Nephrology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (11 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Rheumatology (544 citations), Immunology (383 citations) and Nephrology (128 citations). DT Boumpas has collaborated with scholars based in Greece, United States and Belgium. Frequent co-authors include George Βertsias, H Kritikos, Μαγδαληνή Νάκου, Dimitrios Iliopoulos, Maria Hatziapostolou, Prodromos Sidiropoulos, René Westhovens, Greet Esselens, H. Zeidler and J Rovenský. Their work appears in journals such as Annals of Internal Medicine, Biochemical and Biophysical Research Communications and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact